Clinical Pharmacology of Endothelin Receptor Antagonists Used in the Treatment of Pulmonary Arterial Hypertension
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Pharmacology of Endothelin Receptor Antagonists Used in the Treatment of Pulmonary Arterial Hypertension
Authors
Keywords
Pulmonary Arterial Hypertension, Right Ventricle, Bosentan, Ambrisentan, Pulmonary Arterial Hypertension Patient
Journal
American Journal of Cardiovascular Drugs
Volume 15, Issue 1, Pages 13-26
Publisher
Springer Nature
Online
2014-12-02
DOI
10.1007/s40256-014-0095-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Investigation of mutual pharmacokinetic interactions between macitentan, a novel endothelin receptor antagonist, and sildenafil in healthy subjects
- (2014) Patricia N. Sidharta et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Investigation of the Effect of Macitentan on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Male Subjects
- (2014) Patricia N. Sidharta et al. CLINICAL DRUG INVESTIGATION
- CYP2C9, SLCO1B1, SLCO1B3, and ABCB11 Polymorphisms in Patients With Bosentan-Induced Liver Toxicity
- (2014) M Roustit et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effectiveness of Spironolactone Plus Ambrisentan for Treatment of Pulmonary Arterial Hypertension (from the [ARIES] Study 1 and 2 Trials)
- (2013) Bradley A. Maron et al. AMERICAN JOURNAL OF CARDIOLOGY
- Investigation of the Effects of Ketoconazole on the Pharmacokinetics of Macitentan, a Novel Dual Endothelin Receptor Antagonist, in Healthy Subjects
- (2013) Jacob Atsmon et al. CLINICAL PHARMACOKINETICS
- Association of CYP2C9*2 With Bosentan-Induced Liver Injury
- (2013) S M Markova et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Interaction profile of macitentan, a new non-selective endothelin-1 receptor antagonist, in vitro
- (2013) Johanna Weiss et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Relative bioavailability of a newly developed pediatric formulation of bosentan vs. the adult formulation
- (2013) Marcelo M. Gutierrez et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- An exploratory panel of biomarkers for risk prediction in pulmonary hypertension: Emerging role of CT-proET-1
- (2013) João Silva Marques et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
- (2013) Tomás Pulido et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dysregulated Renin–Angiotensin–Aldosterone System Contributes to Pulmonary Arterial Hypertension
- (2012) Frances S. de Man et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Neurohormonal Axis in Patients with Pulmonary Arterial Hypertension
- (2012) Frances S. de Man et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Endothelin Axis Is Upregulated in Human and Rat Right Ventricular Hypertrophy
- (2012) Jayan Nagendran et al. CIRCULATION RESEARCH
- Relation of Bosentan, Iloprost, and Sildenafil with Growth Factor Levels in Monocrotaline-Induced Pulmonary Hypertension
- (2012) Semra Yigitaslan et al. CLINICAL AND EXPERIMENTAL HYPERTENSION
- Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension
- (2012) Alice Huertas et al. EUROPEAN RESPIRATORY JOURNAL
- Efficacy, safety and pharmacokinetics of bosentan in portopulmonary hypertension
- (2012) L. Savale et al. EUROPEAN RESPIRATORY JOURNAL
- The Discovery of N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N′-propylsulfamide (Macitentan), an Orally Active, Potent Dual Endothelin Receptor Antagonist
- (2012) Martin H. Bolli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Long-Term Hepatic Safety of Ambrisentan in Patients With Pulmonary Arterial Hypertension
- (2012) Ori Ben-Yehuda et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Slow Receptor Dissociation Kinetics Differentiate Macitentan from Other Endothelin Receptor Antagonists in Pulmonary Arterial Smooth Muscle Cells
- (2012) John Gatfield et al. PLoS One
- Absorption, distribution, metabolism, and excretion of macitentan, a dual endothelin receptor antagonist, in humans
- (2012) Shirin Bruderer et al. XENOBIOTICA
- An update on the use of ambrisentan in pulmonary arterial hypertension
- (2012) Michele D’Alto Therapeutic Advances in Respiratory Disease
- Effect of Cyclosporine and Rifampin on the Pharmacokinetics of Macitentan, a Tissue-Targeting Dual Endothelin Receptor Antagonist
- (2011) Shirin Bruderer et al. AAPS Journal
- Long-Term Pulmonary Hemodynamic Effects of Ambrisentan in Pulmonary Arterial Hypertension
- (2011) James R. Klinger et al. AMERICAN JOURNAL OF CARDIOLOGY
- Ambrisentan
- (2011) James E. Frampton American Journal of Cardiovascular Drugs
- Macitentan: entry-into-humans study with a new endothelin receptor antagonist
- (2011) Patricia N. Sidharta et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Sitaxentan-related acute liver failure in a patient with pulmonary arterial hypertension
- (2011) W.-T. N. Lee et al. EUROPEAN RESPIRATORY JOURNAL
- Endothelin receptor expression in idiopathic pulmonary arterial hypertension: effect of bosentan and epoprostenol treatment
- (2011) S. M. Hall et al. EUROPEAN RESPIRATORY JOURNAL
- Clinical Pharmacokinetics and Drug-Drug Interactions of Endothelin Receptor Antagonists in Pulmonary Arterial Hypertension
- (2011) Jürgen Venitz et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Bosentan attenuates right ventricular hypertrophy and fibrosis in normobaric hypoxia model of pulmonary hypertension
- (2011) Gaurav Choudhary et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Treatment of pulmonary arterial hypertension with targeted therapies
- (2011) Dermot S. O'Callaghan et al. Nature Reviews Cardiology
- Autocrine Fibroblast Growth Factor-2 Signaling Contributes to Altered Endothelial Phenotype in Pulmonary Hypertension
- (2010) Ly Tu et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Mutual pharmacokinetic interactions between bosentan and lopinavir/ritonavir in healthy participants
- (2010) Jasper Dingemanse et al. ANTIVIRAL THERAPY
- Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytesThis article is one of a selection of papers published in the two-part special issue entitled 20 Years of Endothelin Research.
- (2010) J. Craig Hartman et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Effect of Steady-State Ambrisentan on the Pharmacokinetics of a Single Dose of the Oral Contraceptive Norethindrone (Norethisterone) 1 mg/Ethinylestradiol 35 μg in Healthy Subjects
- (2010) Rebecca Spence et al. CLINICAL DRUG INVESTIGATION
- Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children
- (2010) A. A. Hislop et al. EUROPEAN RESPIRATORY JOURNAL
- Short and long term anti-inflammatory effects of bosentan therapy in patients with pulmonary arterial hypertension: relation to clinical and hemodynamic responses
- (2010) George K Karavolias et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Bosentan
- (2009) Sohita Dhillon et al. American Journal of Cardiovascular Drugs
- Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 study
- (2009) Maurice Beghetti et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension
- (2009) A. Lavelle et al. EUROPEAN RESPIRATORY JOURNAL
- Liver toxicity: the Achilles' heel of endothelin receptor antagonist therapy?
- (2009) M. M. Hoeper EUROPEAN RESPIRATORY JOURNAL
- Long-Term Ambrisentan Therapy for the Treatment of Pulmonary Arterial Hypertension
- (2009) Ronald J. Oudiz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cellular and Molecular Basis of Pulmonary Arterial Hypertension
- (2009) Nicholas W. Morrell et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Endothelin receptor blockade in the management of pulmonary arterial hypertension: Selective and dual antagonism
- (2009) Terence K. Trow et al. RESPIRATORY MEDICINE
- Ambrisentan Therapy in Patients With Pulmonary Arterial Hypertension Who Discontinued Bosentan or Sitaxsentan Due to Liver Function Test Abnormalities
- (2008) Michael D. McGoon et al. CHEST
- Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
- (2008) Nazzareno Galiè et al. CIRCULATION
- Endothelin receptor antagonists in pulmonary arterial hypertension
- (2008) J. Dupuis et al. EUROPEAN RESPIRATORY JOURNAL
- An antiproliferative BMP-2/PPARγ/apoE axis in human and murine SMCs and its role in pulmonary hypertension
- (2008) Georg Hansmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Pharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist
- (2008) M. Iglarz et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now